Jump to content

Sarah Tabrizi

From Wikipedia, the free encyclopedia

This is an old revision of this page, as edited by ABurzio (talk | contribs) at 06:47, 28 March 2017 (Date of official opening of the Huntington's disease given). The present address (URL) is a permanent link to this revision, which may differ significantly from the current revision.

Sarah Joanna Tabrizi
FMedSci
Sarah Tabrizi in 2013
Sarah Tabrizi in 2013
Known forResearch into neurodegeneration, particularly Huntington's disease
SpouseMichael Nath
AwardsFellowship of the Academy of Medical Sciences, 2014
Scientific career
FieldsNeuroscience
InstitutionsUCL Institute of Neurology;
National Hospital for Neurology and Neurosurgery
Notable studentsEdward Wild (neuroscientist)
Websitehdresearch.ucl.ac.uk

Sarah Tabrizi FMedSci is a British neurologist and neuroscientist in the field of neurodegeneration, particularly Huntington's disease. She is a Professor at the UCL Institute of Neurology; the founder and director of the UCL Huntington's Disease Centre; and an Honorary Consultant Neurologist at the National Hospital for Neurology and Neurosurgery, Queen Square, London, where she established the Multidisciplinary Huntington's Disease Clinic.[1][2][3] The UCL Huntington’s Disease Centre was officially opened on 1 March 2017 by UCL President and Provost Professor Michael Arthur. [4]

Education

Tabrizi studied biochemistry at Heriot-Watt University followed by medicine at Edinburgh University where she graduated with the Gold Medal (Ettles Scholar) for top student.[1] She obtained a PhD at University College London in 2000.[5]

Research

Tabrizi is distinguished for her work on Huntington's disease pathobiology, biomarkers, outcome measures and clinical trials.[6][7] She led the influential multi-site TRACK-HD cohort study of Huntington's disease that established a battery of clinical trial outcome measures.[6] She is the lead Clinical Investigator for the first clinical trial of a 'gene silencing' or huntingtin-lowering drug in Huntington's disease patients.[8] Tabrizi gave a keynote presentation at the 2016 Google Zeitgeist Minds conference about the trial, and the prospect of gene silencing for neurodegenerative disease.[9]

As of November 2016, Tabrizi had authored over 300 publications, with over 12,500 citations for her research.[10]

Awards and honours

Personal life

Tabrizi lives in London with her husband, the author Michael Nath.[5]

References

  1. ^ a b "Iris View Profile". IRIS - UCL. Retrieved 5 May 2016.
  2. ^ "UCL Huntington's Disease Research". hdresearch.ucl.ac.uk.
  3. ^ "Prof Sarah Tabrizi". www.uclh.nhs.uk.
  4. ^ "The UCL Huntington's Disease Centre opens". https://www.ucl.ac.uk/ion/articles/news/hd-centre/. {{cite web}}: External link in |website= (help); Missing or empty |url= (help)
  5. ^ a b c "Who's Who 2016 - Tabrizi, Prof. Sarah Joanna". Who's Who 2016. Retrieved 6 May 2016.
  6. ^ a b Shetty, Priya (June 2012). "Sarah Tabrizi: tracking Huntington's disease". The Lancet. 379 (9831): 2043. doi:10.1016/S0140-6736(12)60884-8.
  7. ^ Mohammadi, Dara (July 2015). "Fast-forwarding treatment for neurodegenerative disorders". The Lancet Neurology. 14 (7): 687–688. doi:10.1016/S1474-4422(15)00110-6.
  8. ^ Gallagher, James. "Landmark Huntington's trial starts". BBC News. BBC News. Retrieved 5 May 2016.
  9. ^ "Sarah Tabrizi - The Human Revolution". Zeitgeist Minds.
  10. ^ "Sarah J Tabrizi - Google Scholar Citations". scholar.google.co.uk.
  11. ^ "Fellow - Academy of Medical Sciences". www.acmedsci.ac.uk.
  12. ^ "Governance - Wellcome". wellcome.ac.uk.
  13. ^ "Journal of Huntington's Disease". www.iospress.nl. Retrieved 13 June 2016.


Stub icon

This United Kingdom biographical article related to medicine is a stub. You can help Wikipedia by expanding it.

Retrieved from "https://en.wikipedia.org/w/index.php?title=Sarah_Tabrizi&oldid=772596242"